Summary
- Current Price
- As of today, RPTX price is $2.65, with unknown change on
- Current Price All-Time High
- RPTX price is currently -94.29% below its historical high of $46.44 set on
- Market Cap
- RPTX current market cap is $114M, up +103.58% over the past 365 days
- PE Ratio
- RPTX PE ratio is unknown
- Revenue
- RPTX current annual revenue is $53.48M, up +4.58% year-over-year
- Next Earnings
- The next earnings release for RPTX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Repare Therapeutics Inc. |
| Ticker | NASDAQ: RPTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Canada |
| IPO | |
| Indexes | Not included |
| Website | reparerx.com |
| Employees | 129 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $2.65 | ||
| Price, 1D Change | - | |
| $114M | ||
| - | ||
| - | ||
| 0.36 | ||
| $53M | ||
| Revenue, 1Y Change | +4.58% | |
| -$2.00 | ||
| EPS, 1Y Change | +10.38% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.00 | ||
| EPS Estimate | -$2.11 | |
| EPS Est. Change | -5.66% | |
| $53.48M | ||
| Revenue Estimate | $7.65M | |
| Revenue Est. Change | -85.69% | |
| $2.65 | ||
| Price Target | - | $3.00 |
| Price Tgt. Change | - | +13.21% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.03 | -$2.23 | -9.77% | |
| -$2.13 | -$2.00 | +6.25% | |
| -$2.11 | N/A | -5.66% | |
| - | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $61.28M | $51.13M | -16.56% | |
| $55.83M | $53.48M | -4.22% | |
| $7.65M | N/A | -85.69% | |
| $10.00M | N/A | -81.30% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +100.76% | ||
| -76.96% | ||
| +103.58% | ||
| -76.37% | ||
| +4.58% | ||
| +603.64% | ||
| +10.38% | ||
| +29.36% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $2.65 | ||
| $1.75 | ||
| SMA 200 vs Price | -33.80% | |
| $2.35 | ||
| SMA 50 vs Price | -11.42% | |
| 0.36 | ||
| $0.05 | ||
| 73.42 | ||
| 9.76% | ||
| 59.56% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $53.48M | ||
| -$2.00 | ||
| $51.56M | ||
| 96.41% | ||
| -$92.14M | ||
| -170.56% | ||
| -$84.69M | ||
| -158.37% | ||
| -$90.22M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.01 | ||
| 6.77 | ||
| 6.77 | ||
| - | ||
| - | ||
| -1.04 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 9.62 | ||
| 0.99 | ||
| -0.03 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $151.13M | ||
| $152.79M | ||
| $176.51M | ||
| $171.15M | ||
| $25.38M | ||
| $25.29M | ||
| $1.93M | ||
| $1.85M | ||
| $3.62M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $145.62M | ||
| $145.62M | ||
| $1.92M | ||
| $29.68M | ||
| $1.92M | ||
| $0.00 | ||
| $1.44M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$76.45M | ||
| $49.47M | ||
| $542.00K | ||
| $0.00 | ||
| -$76.45M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Stifel | → | |
| LifeSci Capital | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with RPTX
FAQ
What is the ticker symbol for Repare Therapeutics Inc.?
The ticker symbol for Repare Therapeutics Inc. is NASDAQ:RPTX
Does Repare Therapeutics Inc. pay dividends?
No, Repare Therapeutics Inc. does not pay dividends
What sector is Repare Therapeutics Inc. in?
Repare Therapeutics Inc. is in the Healthcare sector
What industry is Repare Therapeutics Inc. in?
Repare Therapeutics Inc. is in the Biotechnology industry
What country is Repare Therapeutics Inc. based in?
Repare Therapeutics Inc. is headquartered in Canada
When did Repare Therapeutics Inc. go public?
Repare Therapeutics Inc. initial public offering (IPO) was on June 19, 2020
Is Repare Therapeutics Inc. in the S&P 500?
No, Repare Therapeutics Inc. is not included in the S&P 500 index
Is Repare Therapeutics Inc. in the NASDAQ 100?
No, Repare Therapeutics Inc. is not included in the NASDAQ 100 index
Is Repare Therapeutics Inc. in the Dow Jones?
No, Repare Therapeutics Inc. is not included in the Dow Jones index
When was Repare Therapeutics Inc. last earnings report?
Repare Therapeutics Inc.'s most recent earnings report was on November 14, 2025
When does Repare Therapeutics Inc. report earnings?
The next expected earnings date for Repare Therapeutics Inc. is March 3, 2026
Data Sources & References
- RPTX Official Website www.reparerx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1808158/000119312525283336/0001193125-25-283336-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1808158/000095017025030405/0000950170-25-030405-index.htm
- RPTX Profile on Yahoo Finance finance.yahoo.com/quote/RPTX
- RPTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rptx